CompletedPHASE1, PHASE2NCT00519818
Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia
Studying Adrenogenital syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Neurocrine UK Limited
- Principal Investigator
- Deborah Merck, MDNational Institutes of Health (NIH)
- Intervention
- Chronocort(drug)
- Enrollment
- 20 enrolled
- Eligibility
- 16-60 years · All sexes
- Timeline
- 2007 – 2009
Study locations (1)
- National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Collaborators
National Institutes of Health Clinical Center (CC)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00519818 on ClinicalTrials.gov